Zhejiang Chimin Pharm Co Ltd (603222) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Chimin Pharm Co Ltd (603222) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥3.84 Million ≈ $562.44K USD) by net assets (CN¥1.49 Billion ≈ $217.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Chimin Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Zhejiang Chimin Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 603222 liabilities breakdown for a breakdown of total debt and financial obligations.
Zhejiang Chimin Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Chimin Pharm Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shanghai Xuerong Bio-Technology Co Ltd
SHE:300511
|
-0.053x |
|
MCAN Mortgage Corporation
TO:MKP
|
1.061x |
|
Shakti Pumps (India) Limited
NSE:SHAKTIPUMP
|
-0.294x |
|
Zhejiang Noblelift Equip
SHG:603611
|
0.154x |
|
KBC Corporation Ltd
SHG:688598
|
-0.006x |
|
Sobute New Materials Co Ltd
SHG:603916
|
0.044x |
|
Qiaoyin Environmental Tech Co Ltd
SHE:002973
|
0.015x |
|
Jiangyin Pivot Automotive Products Co. Ltd.
SHE:301181
|
0.011x |
Annual Cash Flow Conversion Efficiency for Zhejiang Chimin Pharm Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Chimin Pharm Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Zhejiang Chimin Pharm Co Ltd stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.57 Billion ≈ $229.47 Million |
CN¥72.99 Million ≈ $10.68 Million |
0.047x | -44.90% |
| 2023-12-31 | CN¥1.66 Billion ≈ $242.89 Million |
CN¥140.20 Million ≈ $20.52 Million |
0.084x | -26.76% |
| 2022-12-31 | CN¥1.77 Billion ≈ $259.65 Million |
CN¥204.65 Million ≈ $29.95 Million |
0.115x | -45.24% |
| 2021-12-31 | CN¥1.37 Billion ≈ $201.14 Million |
CN¥289.49 Million ≈ $42.36 Million |
0.211x | +32.51% |
| 2020-12-31 | CN¥1.05 Billion ≈ $153.10 Million |
CN¥166.29 Million ≈ $24.33 Million |
0.159x | +11.61% |
| 2019-12-31 | CN¥1.07 Billion ≈ $156.99 Million |
CN¥152.77 Million ≈ $22.36 Million |
0.142x | +20.21% |
| 2018-12-31 | CN¥1.05 Billion ≈ $153.15 Million |
CN¥123.99 Million ≈ $18.14 Million |
0.118x | +65.39% |
| 2017-12-31 | CN¥928.28 Million ≈ $135.84 Million |
CN¥66.49 Million ≈ $9.73 Million |
0.072x | -19.65% |
| 2016-12-31 | CN¥808.94 Million ≈ $118.37 Million |
CN¥72.12 Million ≈ $10.55 Million |
0.089x | -23.45% |
| 2015-12-31 | CN¥750.99 Million ≈ $109.89 Million |
CN¥87.46 Million ≈ $12.80 Million |
0.116x | -33.52% |
| 2014-12-31 | CN¥441.55 Million ≈ $64.61 Million |
CN¥77.36 Million ≈ $11.32 Million |
0.175x | -20.95% |
| 2013-12-31 | CN¥488.13 Million ≈ $71.43 Million |
CN¥108.19 Million ≈ $15.83 Million |
0.222x | -43.57% |
| 2012-12-31 | CN¥432.53 Million ≈ $63.29 Million |
CN¥169.88 Million ≈ $24.86 Million |
0.393x | +357.29% |
| 2011-12-31 | CN¥383.04 Million ≈ $56.05 Million |
CN¥32.90 Million ≈ $4.81 Million |
0.086x | -- |
About Zhejiang Chimin Pharm Co Ltd
Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells vitro diagnostic products and provides medical services in China and internationally. The company provides non-PVC double-tube double-valve, single-tube single-valve, and single-tube double-valve soft bags; plastic bottles; and other packaging forms. It also offers medical instruments, in… Read more